| Serial Number | 76720853 |
| Word Mark | BIOTEST |
| Filing Date | Friday, June 24, 2022 |
| Status | 733 - FOURTH EXTENSION - GRANTED |
| Status Date | Thursday, September 4, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, August 29, 2023 |
| Goods and Services | Pharmaceutical preparations for treating infectious diseases and diseases of the immune system, namely, proteins and protein preparations made from human blood, blood plasma or blood serum; pharmaceutical preparations for the treatment or prevention of blood or bleeding disorders, namely, human albumin, coagulation factors and coagulation inhibitors, in particular factor VIII, factor IX, factor X, fibrinogen; pharmaceutical preparations for the treatment or prevention of blood or bleeding disorders, namely, immunoglobulin preparations, immunoglobulins and hyperimmunoglobulins; pharmaceutical preparations for the treatment or prevention of blood or bleeding disorders, namely, recombinant proteins, in particular coagulation factors and monoclonal antibodies; pharmaceutical preparations for haematology, immunology, neurology, intensive medicine, transplantation medicine, oncology for the prevention and treatment of immune system-related diseases and disorders, neurological diseases and disorders, cancer and infections; pharmaceutical preparations for preventing and treating viral diseases, for treating diseases of the immune system, for treating autoimmune diseases and oncological diseases; immunosuppressant, immunomodulatory, anti-inflammatory, antiallergic, hyposensitizing and detoxifying and toxin-neutralizing medicines |
| Pseudo Mark | BIO TEST |
| Goods and Services | Biological preparations for use in industry and science, namely, proteins and protein preparations made from human blood, blood plasma or blood serum, in particular human albumin, coagulation factors and immunoglobulins; recombinant proteins for industrial and scientific use; plasma fractions in the nature of biological preparations for industrial and scientific use; excipients for the stabilization of medicines, in particular human albumin for industrial and scientific purposes |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, June 24, 2022 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, June 24, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Biotest AG |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 25 - NOT AVAILABLE |
| Address | Dreieich 63303 DE |
| Party Name | Biotest AG |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 25 - NOT AVAILABLE |
| Address | DE |
| Event Date | Event Description |
| Wednesday, June 22, 2022 | REQUEST FOR TRANSFORMATION PROCESSED - TOTAL |
| Wednesday, June 22, 2022 | ASSIGNED TO EXAMINER |
| Friday, June 24, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Tuesday, June 28, 2022 | APPLICATION FILING RECEIPT MAILED |
| Monday, April 10, 2023 | ASSIGNED TO EXAMINER |
| Thursday, April 13, 2023 | NON-FINAL ACTION WRITTEN |
| Thursday, April 13, 2023 | NON-FINAL ACTION MAILED |
| Thursday, July 13, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, July 13, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, July 13, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, July 24, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, August 9, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, August 29, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, August 29, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, October 24, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Monday, May 27, 2024 | ABANDONMENT - NO USE STATEMENT FILED |
| Wednesday, April 24, 2024 | SOU EXTENSION 1 FILED |
| Friday, July 12, 2024 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Thursday, August 15, 2024 | NOTICE OF REVIVAL - E-MAILED |
| Thursday, August 15, 2024 | PETITION TO REVIVE-GRANTED |
| Thursday, August 15, 2024 | SOU EXTENSION RECEIVED WITH TEAS PETITION |
| Thursday, August 15, 2024 | TEAS PETITION TO REVIVE RECEIVED |
| Wednesday, September 25, 2024 | SOU EXTENSION 1 GRANTED |
| Wednesday, September 25, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, October 7, 2024 | SOU EXTENSION 2 FILED |
| Monday, October 7, 2024 | SOU EXTENSION 2 GRANTED |
| Friday, April 4, 2025 | SOU TEAS EXTENSION RECEIVED |
| Monday, October 7, 2024 | SOU TEAS EXTENSION RECEIVED |
| Monday, October 7, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, April 4, 2025 | SOU EXTENSION 3 FILED |
| Friday, April 4, 2025 | SOU EXTENSION 3 GRANTED |
| Saturday, April 5, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, September 4, 2025 | SOU TEAS EXTENSION RECEIVED |
| Thursday, September 4, 2025 | SOU EXTENSION 4 FILED |
| Thursday, September 4, 2025 | SOU EXTENSION 4 GRANTED |
| Monday, September 15, 2025 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |